ALESSIO, NICCOLÒ LEANDRO
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 110
AS - Asia 91
SA - Sud America 10
AF - Africa 4
Totale 347
Nazione #
US - Stati Uniti d'America 129
CN - Cina 27
DE - Germania 23
IT - Italia 23
SG - Singapore 23
RU - Federazione Russa 18
HK - Hong Kong 17
IE - Irlanda 17
FI - Finlandia 13
VN - Vietnam 10
GB - Regno Unito 7
BR - Brasile 6
IN - India 3
JP - Giappone 3
VE - Venezuela 3
CA - Canada 2
FR - Francia 2
IL - Israele 2
PL - Polonia 2
SE - Svezia 2
TR - Turchia 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DM - Dominica 1
EC - Ecuador 1
EG - Egitto 1
IQ - Iraq 1
NL - Olanda 1
TM - Turkmenistan 1
UA - Ucraina 1
Totale 347
Città #
Dallas 20
Hong Kong 17
Chandler 16
Munich 15
Dublin 13
Singapore 13
Beijing 11
New York 11
Ashburn 9
Turku 8
Los Angeles 6
Boardman 5
Helsinki 5
Shanghai 5
Ho Chi Minh City 4
Moscow 4
Reggio Emilia 3
Seattle 3
Tokyo 3
Ankara 2
Buffalo 2
Chennai 2
Denver 2
Düsseldorf 2
Hanoi 2
Lawrence 2
Medford 2
Monza 2
Ospitaletto 2
Poplar 2
Princeton 2
Redondo Beach 2
Rome 2
Stockholm 2
São Paulo 2
The Dalles 2
Warsaw 2
Abidjan 1
Ashgabat 1
Baghdad 1
Boston 1
Brooklyn 1
Brussels 1
Bắc Giang 1
Cairo 1
Catania 1
Ciudad Guayana 1
Columbus 1
Cuenca 1
Da Nang 1
Des Moines 1
Dongying 1
Falkenstein 1
Guarenas 1
Guarulhos 1
Haifa 1
Hamad Town 1
Handan 1
Houston 1
Itajaí 1
Jesúpolis 1
Jinan 1
Johannesburg 1
Lauterbourg 1
London 1
Maracay 1
Memphis 1
Milan 1
Montreal 1
Nuremberg 1
Orem 1
Pune 1
Roseau 1
Rovello Porro 1
San Diego 1
Santa Clara 1
São João do Piauí 1
Tianjin 1
Totale 248
Nome #
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 102
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 72
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 70
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 62
Vaccine hesitancy in patients with solid tumors: a cross-sectional single-center survey 47
Totale 353
Categoria #
all - tutte 1.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 0 0 0 0 0 0 7 2 6
2022/202346 3 5 0 6 4 2 0 1 17 0 8 0
2023/202450 5 8 2 1 2 17 3 3 0 1 3 5
2024/2025113 5 4 2 1 0 11 3 10 27 5 17 28
2025/2026129 16 13 28 26 35 11 0 0 0 0 0 0
Totale 353